Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1
Myotonic dystrophy type 1 (DM1) is an autosomal dominant genetic disease characterized by multi-system involvement. Affected organ system includes skeletal muscle, heart, gastro-intestinal system and the brain. In this review, we evaluate the evidence for alterations in insulin signaling and their r...
Main Authors: | Sylvia Nieuwenhuis, Kees Okkersen, Joanna Widomska, Paul Blom, Peter A. C. 't Hoen, Baziel van Engelen, Jeffrey C. Glennon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.01229/full |
Similar Items
-
Editorial: Myotonic Dystrophies: Developments in Research From Bench to Bedside
by: Gabriella Silvestri, et al.
Published: (2020-09-01) -
Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin
by: Tiago Mateus, et al.
Published: (2021-02-01) -
Core Clinical Phenotypes in Myotonic Dystrophies
by: Stephan Wenninger, et al.
Published: (2018-05-01) -
Fetal Macrocephaly: A Novel Sonographic Finding in Congenital Myotonic Dystrophy
by: Shiri Shinar, et al.
Published: (2020-07-01) -
Non-Alcoholic Steatohepatitis in Myotonic Dystrophy: DMPK Gene Mutation, Insulin Resistance and Development of Steatohepatitis
by: Rishi R. Bhardwaj, et al.
Published: (2010-03-01)